Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT

Author(s): Zhiwei Li, Junli Guo, Keping Xie, Shaojiang Zheng

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 10 , 2015

Become EABM
Become Reviewer
Call for Editor


Pancreatic ductal adenocarcinoma (PDAC) still remains one of the most fatal human malignant tumors. Long-term survival rate is still extremely pathetic even for patients who receive surgery. Epithelial-to-mesenchymal transition (EMT), which is a physiologic process of morphological as well as genetic changes in carcinoma cells, plays a vital role in aggressiveness of PDAC. Meanwhile EMT is also the reason why pancreatic cancer cells achieve such huge metastatic potentials. Many tumor microenvironmental factors such as cytokines, growth factors, as well as chemotherapeutic agents may induce EMT. Our study provides evidence regarding effects of EMT on pancreatic cancer progression, focusing on the correlation between EMT and other pathways which are crucial to tumor progression, especially vitamin D receptor signaling pathway. Research on signal pathways resulting in EMT inactivation during these disease processes may offer innovative ideas on plasticity of cellular phenotypes as well as possible therapeutic interventions.

Keywords: Pancreatic ductal adenocarcinoma, vitamin D receptor, epithelial-to-mesenchymal transition.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 03 February, 2015
Page: [1262 - 1267]
Pages: 6
DOI: 10.2174/1381612821666141211151138
Price: $65

Article Metrics

PDF: 68